CORD-19:35349bb1fc9290338907b7d7f104c9db3951163b / 293919-294106 JSONTXT

Annnotations TAB JSON ListView MergeView

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/35349bb1fc9290338907b7d7f104c9db3951163b","sourcedb":"CORD-19","sourceid":"35349bb1fc9290338907b7d7f104c9db3951163b","text":"This impaired clearance results in higher serum concentrations in comparison to patients with normal kidney function and reduction of dosing interval is recommended to avoid side effects.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T2138","span":{"begin":0,"end":187},"obj":"Sentence"},{"id":"T33974","span":{"begin":0,"end":187},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T2138","pred":"source","obj":"CORD-19-Sentences"},{"subj":"T33974","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T612","span":{"begin":42,"end":47},"obj":"Body_part"},{"id":"T613","span":{"begin":101,"end":107},"obj":"Body_part"}],"attributes":[{"id":"A612","pred":"uberon_id","subj":"T612","obj":"http://purl.obolibrary.org/obo/UBERON_0001977"},{"id":"A613","pred":"uberon_id","subj":"T613","obj":"http://purl.obolibrary.org/obo/UBERON_0002113"},{"subj":"T612","pred":"source","obj":"CORD-19-PD-UBERON"},{"subj":"T613","pred":"source","obj":"CORD-19-PD-UBERON"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#d693ec","default":true},{"id":"CORD-19-PD-UBERON","color":"#93ecbc"}]}]}}